$9.90
0.202.06%
At close: Jun 17, 5:00 PM EST
$10.05
0.151.52%
After Hours: 5:16 PM EST
ARS Pharmaceuticals Inc Earnings Estimates
SPRYNASDAQ
ARS Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:SPRY
ARS Pharmaceuticals (SPRY) is scheduled to report Q2 earnings on August 12, 2026. Analysts estimate EPS of $-0.52 and quarterly revenue of $32.07M.
In the most recent quarter (Q1), ARS Pharmaceuticals reported EPS of $-0.61, missing estimates of $-0.53 by 0.15%. Revenue came in at $22.68M, exceeding the estimate of $22.14M by 0.02%.
Over the last 4 quarters, ARS Pharmaceuticals has averaged an EPS surprise of 0.09% and a revenue surprise of 0.09%.
Earnings Date
Aug 12
EPS Estimate
$-0.520
Quarterly Revenue Estimate
$32.07M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$98.99M
ARS Pharmaceuticals Earnings History
Analyze the earnings history of ARS Pharmaceuticals using advanced sorting and filters.
Loading calendar...
ARS Pharmaceuticals (SPRY) Earnings Per Share
The chart below shows ARS Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
ARS Pharmaceuticals (SPRY) Revenue
The chart below shows ARS Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is ARS Pharmaceuticals (NASDAQ:SPRY) reporting earnings?
ARS Pharmaceuticals (SPRY) is scheduled to report earnings on August 12, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
What were the latest earnings per share (EPS) for ARS Pharmaceuticals (NASDAQ:SPRY)?
The Actual EPS was $-0.61, which missed the estimate of $-0.53.
What were ARS Pharmaceuticals’s (NASDAQ:SPRY) revenues?
The Actual Revenue was $22.68M, which beat the estimate of $22.14M.
